Old Web
English
Sign In
Acemap
>
authorDetail
>
Daniel T Barnes
Daniel T Barnes
University Hospitals of Leicester NHS Trust
Mesothelioma
Oncology
Medicine
Internal medicine
Nivolumab
3
Papers
35
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
CONFIRM: A phase III randomized trial to evaluate the efficacy of nivolumab versus placebo in relapsed mesothelioma.
2018
Journal of Clinical Oncology
Dean A. Fennell
Emma Kirkpatrick
Kelly Cozens
Sarah Danson
G.G. Hanna
J.F. Lester
Joanne Lord
Mavis Nye
Christian Ottensmeier
Peter W. Szlosarek
Nicola Steele
Daniel T Barnes
Karan Vadher
Tom Maishman
Stephanie Hill
Gareth Griffiths
Show All
Source
Cite
Save
Citations (0)
CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial
2018
Trials
Dean A. Fennell
Emma Kirkpatrick
Kelly Cozens
Mavis Nye
J.F. Lester
G.G. Hanna
Nicola Steele
Peter W. Szlosarek
Sarah Danson
Joanne Lord
Christian Ottensmeier
Daniel T Barnes
Stephanie Hill
Michail Kalevras
Tom Maishman
Gareth Griffiths
Show All
Source
Cite
Save
Citations (33)
MA12.05 Phase 1 Study of HSP90 Inhibitor Ganetespib with Pemetrexed and Cisplatin/Carboplatin Chemotherapy for Pleural Mesothelioma
2018
Journal of Thoracic Oncology
Dean A. Fennell
Sarah Danson
Martin Forster
Denis C. Talbot
Penella J. Woll
J. Child
Yenting Ngai
Laura Farrelly
A Hackshaw
A. Sharkey
Sara Busacca
R. Hastings
Daniel T Barnes
Marianne Nicolson
Paul Taylor
S. Ahmed
G. Wheeler
Show All
Source
Cite
Save
Citations (2)
1